Jose A Castro-Rodriguez1, Andrea A Beckhaus1, Erick Forno2. 1. Division of Pediatrics, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile. 2. Division of Pediatric Pulmonary Medicine, Allergy, and Immunology, Children's Hospital of Pittsburgh of UPMC, University of Pittsburgh, Pittsburgh, Pennsylvania.
Abstract
RATIONALE: Systemic corticosteroids (SCS) are used for treat preschoolers with acute asthma or wheezing exacerbations, with conflicting results. OBJECTIVE: To evaluate the effectiveness of oral corticosteroids (OCS) compared to placebo in preschoolers presenting with acute asthma/wheezing exacerbations. METHODS: Five electronic databases were searched for all placebo-controlled, randomized clinical trials of OCS in children <6 years of age presenting with recurrent wheezing/asthma exacerbations of any severity. Primary outcomes were hospitalizations, unscheduled emergency department (ED) visits in following month, need of additional OCS courses, and length of stay (ED or hospital). RESULTS: Eleven studies met inclusion criteria (n = 1,733); four were conducted on an outpatient basis, five in inpatients, and two in the ED. Significant heterogeneity was found when pooling all studies, and thus analysis was stratified by trial setting. Among the outpatient studies, children who received OCS had a higher hospitalization rate (RR: 2.15 [95%CI = 1.08-4.29], I(2) = 0%) compared to those to received placebo. Among the ED studies, children who received OCS had a lower risk of hospitalization (RR: 0.58 [0.37-0.92], I(2) = 0%). Among the inpatient studies, children who received OCS needed fewer additional OCS courses than those on placebo (RR: 0.57 [0.40-0.81], I(2) = 0%). CONCLUSIONS: Treatment with OCS in the ED or hospital may be beneficial in toddlers and preschoolers with frequent asthma/wheezing exacerbations. However, more studies are needed before OCS can be broadly recommended for this age group. Future trials should be carefully designed to avoid bias and according to our findings regarding administration setting. Pediatr Pulmonol. 2016;51:868-876.
RATIONALE: Systemic corticosteroids (SCS) are used for treat preschoolers with acute asthma or wheezing exacerbations, with conflicting results. OBJECTIVE: To evaluate the effectiveness of oral corticosteroids (OCS) compared to placebo in preschoolers presenting with acute asthma/wheezing exacerbations. METHODS: Five electronic databases were searched for all placebo-controlled, randomized clinical trials of OCS in children <6 years of age presenting with recurrent wheezing/asthma exacerbations of any severity. Primary outcomes were hospitalizations, unscheduled emergency department (ED) visits in following month, need of additional OCS courses, and length of stay (ED or hospital). RESULTS: Eleven studies met inclusion criteria (n = 1,733); four were conducted on an outpatient basis, five in inpatients, and two in the ED. Significant heterogeneity was found when pooling all studies, and thus analysis was stratified by trial setting. Among the outpatient studies, children who received OCS had a higher hospitalization rate (RR: 2.15 [95%CI = 1.08-4.29], I(2) = 0%) compared to those to received placebo. Among the ED studies, children who received OCS had a lower risk of hospitalization (RR: 0.58 [0.37-0.92], I(2) = 0%). Among the inpatient studies, children who received OCS needed fewer additional OCS courses than those on placebo (RR: 0.57 [0.40-0.81], I(2) = 0%). CONCLUSIONS: Treatment with OCS in the ED or hospital may be beneficial in toddlers and preschoolers with frequent asthma/wheezing exacerbations. However, more studies are needed before OCS can be broadly recommended for this age group. Future trials should be carefully designed to avoid bias and according to our findings regarding administration setting. Pediatr Pulmonol. 2016;51:868-876.
Authors: Tuomas Jartti; Pasi Lehtinen; Timo Vanto; Jaakko Hartiala; Tytti Vuorinen; Mika J Mäkelä; Olli Ruuskanen Journal: Pediatr Infect Dis J Date: 2006-06 Impact factor: 2.129
Authors: Roger Zemek; Amy Plint; Martin H Osmond; Tom Kovesi; Rhonda Correll; Nicholas Perri; Nick Barrowman Journal: Pediatrics Date: 2012-03-19 Impact factor: 7.124
Authors: M Diane Lougheed; Nancy Garvey; Kenneth R Chapman; Lisa Cicutto; Robert Dales; Andrew G Day; Wilma M Hopman; Miu Lam; Malcolm R Sears; Kim Szpiro; Teresa To; Nigel A M Paterson Journal: Chest Date: 2006-04 Impact factor: 9.410
Authors: Francine M Ducharme; Gilles Chabot; Constantin Polychronakos; Francis Glorieux; Bruce Mazer Journal: Pediatrics Date: 2003-02 Impact factor: 7.124
Authors: Tuomas Jartti; Pasi Lehtinen; Timo Vanto; Tytti Vuorinen; Heikki Hiekkanen; Jaakko Hartiala; Mika J Mäkelä; Olli Ruuskanen Journal: Pediatr Pulmonol Date: 2007-12